SCHEMBL4283513

SCHEMBL4283513

COc1ccccc1N=Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 10/20 0.54
▸ MEN1 O00255 9/20 0.54
▸ RAB9A P51151 6/20 0.48
▸ NPC1 O15118 5/20 0.48
▸ MAPT P10636 6/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ TNNI3 P19429 1/20 0.48
▸ TNNT2 P45379 1/20 0.48
▸ TNNC1 P63316 1/20 0.48
▸ KEAP1 Q14145 1/20 0.48
▸ NFE2L2 Q16236 1/20 0.48
▸ TDP1 Q9NUW8 2/20 0.47
▸ CASP3 P42574 2/20 0.47
▸ SENP7 Q9BQF6 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4283506 1.00 KMT2A (0.54) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL13593604 0.85 MEN1 (0.52) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL28543339 0.82 MEN1 (0.58) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL28543338 0.82 MEN1 (0.58) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL3654723 0.81 KMT2A (0.54) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL7198643 0.81 KMT2A (0.54) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL3654726 0.81 KMT2A (0.54) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL11746386 0.81 MEN1 (0.64) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL14823076 0.81 MEN1 (0.50) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL17787274 0.80 MEN1 (0.50) KMT2AMEN1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104230747-A Preparation method of asymmetric aromatic azo compound SINOPHARM CHEMICAL REAGENT CO LTD 2014-12-24 — — CN disclosed
US-8198436-B2 Colorimetric detection of cyanide with a chromogenic oxazine THE UNIVERSITY OF MIAMI (US) 2012-06-12 — — US disclosed
US-20090258429-A1 Colorimetric detection of cyanide with a chromogenic oxazine MIAMI, THE UNIVERSITY OF 2009-10-15 — — US disclosed
WO-2007028080-A1 COLORIMETRIC DETECTION OF CYANIDE WITH A CHROMOGENIC OXAZINE THE UNIVERSITY OF MIAMI (US) 2007-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258429-A1 Colorimetric detection of cyanide with a chromogenic oxazine CBR3, CBR1, CYCS KMT2A 3788/4885MEN1 4062/4885RAB9A 4466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback